Mapping long-range interactions in α-synuclein using spin-label NMR and ensemble molecular dynamics simulations; Metastability of native proteins and the phenomenon of amyloid formation; Cisplatin binding sites on human albumin; Multi-metal binding site of serum albumin; Heat shock protein 70 inhibits α-synuclein fibril formation via preferential binding to prefibrillar species; Structure and properties of a complex of α-synuclein and a single-domain camelid antibody; Two-dimensional NMR lineshape analysis; Cytochrome display on amyloid fibrils; The interaction of αB-crystallin with mature α-synuclein amyloid fibrils inhibits their elongation; Targeting the intrinsically disordered structural ensemble of α-synuclein by small molecules as a potential therapeutic strategy for Parkinson’s disease; Protein folding on the ribosome; A coupled equilibrium shift mechanism in calmodulin-mediated signal transduction; Structure and dynamics of a ribosome-bound nascent chain by NMR spectroscopy; A structural ensemble of a ribosome–nascent chain complex during cotranslational protein folding; Chaperone proteostasis in Parkinson's disease: Stabilization of the Hsp70/α‐synuclein complex by Hip; Molecular determinants of the aggregation behavior of α‐and β‐synuclein; Nanobodies raised against monomeric α-synuclein distinguish between fibrils at different maturation stages; A New Structural Transition of Serum Albumin Dependent on the State of Cys34: Detection by 1H‐NMR Spectroscopy; On the mechanism of nonspecific inhibitors of protein aggregation: dissecting the interactions of α-synuclein with Congo red and lacmoid; Immunological features of α‐synuclein in Parkinson's disease
